A multicenter, open-label clinical study of micafungin (FK463) in the treatment of deep-seated mycosis in Japan.
about
Comparison of echinocandin antifungalsAccumulated safety data of micafungin in therapy and prophylaxis in fungal diseases.Micafungin.Micafungin in premature and non-premature infants: a systematic review of 9 clinical trials.Calcium oxalate in the sputum may aid in the diagnosis of pulmonary aspergillosis: A report of two cases.Safety and Effectiveness of Micafungin in Japanese Pediatric Patients: Results of a Postmarketing Surveillance Study.Micafungin: pharmacology, experimental therapeutics and clinical applications.Echinocandins: role in antifungal therapy, 2005.Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trialEchinocandin antifungals: review and update.Emerging echinocandins for treatment of invasive fungal infections.Treatment options for invasive fungal infections.Efficacy of SPK-843, a novel polyene antifungal, in comparison with amphotericin B, liposomal amphotericin B, and micafungin against murine pulmonary aspergillosisNew agents for the treatment of fungal infections: clinical efficacy and gaps in coverage.Micafungin: a new echinocandin antifungal.The echinocandins.Nosocomial fungal infections: epidemiology, diagnosis, and treatment.Micafungin sodium, the second of the echinocandin class of antifungals: theory and practice.A comparative evaluation of properties and clinical efficacy of the echinocandins.Current options in antifungal pharmacotherapy.Caspofungin for treatment of invasive aspergillus infections.Management of fungal infections following allogeneic stem cell transplantation.Review of the pharmacology and clinical studies of micafunginEchinocandin pharmacodynamics: review and clinical implications.New β-glucan inhibitors as antifungal drugs.Itraconazole in chronic cavitary pulmonary aspergillosis: a randomised controlled trial and systematic review of literature.Clinical characteristics and treatment outcomes of chronic pulmonary aspergillosis.Direct transbronchial administration of liposomal amphotericin B into a pulmonary aspergilloma.Echinocandins in antifungal pharmacotherapy.Efficacy and safety of micafungin as an empirical antifungal therapy for suspected fungal infection in neutropenic patients with hematological disorders.Efficacy and safety of micafungin, an echinocandin antifungal agent, on invasive fungal infections in patients with hematological disorders.Early clinical experience with anidulafungin at a large tertiary care medical center.Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis.
P2860
Q28273738-AA3746AA-0288-41FE-9C04-FFCE82F3DECFQ33816237-57D6B82B-AB63-45AD-98EF-A891300B3915Q33981019-AE9BE034-1EB7-4DD0-A0FF-B875D69FB185Q34337608-B1655008-DB9D-45BA-87A7-9ECDA15AC5E2Q35196780-8603F1CC-DB51-4770-98A9-EA00EF4EF207Q35787372-84433AAC-1F9D-484F-86F0-633A607C8320Q36120798-672567C2-D2D0-4E9F-BB2D-24D26131D9F3Q36222035-A6EDAEBF-8229-4E45-B6CF-4FCB97AD90F6Q36342188-BF839DC3-EAA5-45F4-84AF-F08A8578FAF8Q36441524-A9FB6986-B8C1-4C47-B496-1039E76AD0ECQ36458402-844E4F47-FA50-4C5C-A9CF-1E74C6E5E459Q36484945-F883565E-C0DD-4521-8330-9FACAD373BE9Q36593863-066C02FB-2827-4E03-9E6D-639E6ABF011CQ36597431-FF7741BD-70DF-4C12-A32F-CD066B544226Q36693843-CF7D42F5-387A-4F47-A7E3-DE45D9F6196CQ36742397-E6280D59-1AA6-434F-9522-1DD41672C16BQ36825717-5D0AEDBA-8C8E-4B86-924F-3C93ABD47793Q36895679-F92D16CB-6E28-48B1-B9E1-4871C59840DDQ36895839-221090E0-34F5-4A51-9409-E92F27AC1B03Q37151326-67C1970E-2B36-4382-BA17-49F3EA098005Q37159584-C668F8C7-787E-474A-8947-9F123D5A063EQ37202860-01F07B86-F14F-4682-8114-468CDAF8E1B0Q37669740-7FE6529F-3754-4C40-A635-7B815D1CF9BAQ37718385-571BCAD9-A1F4-42D6-959E-630DCCDC2543Q37905055-B4F79AC4-6E1B-4926-BE51-5CA48849FF79Q38089925-1CD23471-9A69-463B-A24A-531A7033A886Q38120032-990F537D-4CF8-41BE-9488-26AE63571581Q38556616-AA22DC00-FCBB-4C3B-B129-DDFD7D024FA2Q39458862-90B7DA85-E881-4B8E-B113-8A9C94A13551Q40313049-F5CE6A9C-CD9D-4187-984A-BA50030BC85AQ43468516-C592AA39-059B-4BDF-98FA-CB707E8DCA62Q46836740-3FCE1802-EF62-4AA9-A84B-AC9C0ADADBE4Q53696861-D275F607-3C3E-4888-B905-C1876731B6E9
P2860
A multicenter, open-label clinical study of micafungin (FK463) in the treatment of deep-seated mycosis in Japan.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
A multicenter, open-label clin ...... deep-seated mycosis in Japan.
@ast
A multicenter, open-label clin ...... deep-seated mycosis in Japan.
@en
type
label
A multicenter, open-label clin ...... deep-seated mycosis in Japan.
@ast
A multicenter, open-label clin ...... deep-seated mycosis in Japan.
@en
prefLabel
A multicenter, open-label clin ...... deep-seated mycosis in Japan.
@ast
A multicenter, open-label clin ...... deep-seated mycosis in Japan.
@en
P2093
P2860
P1476
A multicenter, open-label clin ...... deep-seated mycosis in Japan.
@en
P2093
Akio Urabe
Hideo Ikemoto
Hideyo Yamaguchi
Shigeru Kohno
Takeshi Mori
Toru Masaoka
Yoshihito Niki
P2860
P304
P356
10.1080/00365540410020406
P577
2004-01-01T00:00:00Z